Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
暂无分享,去创建一个
Y. Barenholz | R. Cohen | G. Haran | Y Barenholz | L K Bar | R Cohen | G Haran | L. Bar
[1] N. Clement,et al. Pyranine (8-hydroxy-1,3,6-pyrenetrisulfonate) as a probe of internal aqueous hydrogen ion concentration in phospholipid vesicles. , 1981, Biochemistry.
[2] F. Arcamone. Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture. , 1985, Cancer research.
[3] Y. Barenholz,et al. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers. , 1983, Cancer research.
[4] S. Schulman,et al. Electronic absorption spectra and protolytic equilibria of doxorubicin: direct spectrophotometric determination of microconstants. , 1977, Journal of pharmaceutical sciences.
[5] L. Mayer,et al. Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. , 1985, Biochimica et biophysica acta.
[6] L. Mayer,et al. Vesicles of variable sizes produced by a rapid extrusion procedure. , 1986, Biochimica et biophysica acta.
[7] D. Deamer,et al. Catecholamine uptake and concentration by liposomes maintaining p/ gradients. , 1976, Biochimica et biophysica acta.
[8] E. Goormaghtigh,et al. Anthracycline glycoside-membrane interactions. , 1984, Biochimica et biophysica acta.
[9] D. Deamer,et al. Permeability of lipid bilayers to water and ionic solutes. , 1986, Chemistry and physics of lipids.
[10] T. Burke,et al. Location and dynamics of anthracyclines bound to unilamellar phosphatidylcholine vesicles. , 1985, Biochemistry.
[11] Y. Barenholz,et al. Liposomes: preparation, characterization, and preservation. , 2006 .
[12] L. Mayer,et al. Influence of ion gradients on the transbilayer distribution of dibucaine in large unilamellar vesicles. , 1988, Biochemistry.
[13] Wilfred D. Stein,et al. Transport and Diffusion Across Cell Membranes , 1986 .
[14] M. Bally,et al. Generation of multilamellar and unilamellar phospholipid vesicles , 1986 .
[15] D. Crommelin,et al. The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. , 1985, Biochimica et biophysica acta.
[16] D. Crommelin,et al. Hydrolysis of phosphatidylcholine in aqueous liposome dispersions , 1989 .
[17] D W Deamer,et al. Light-dependent pH gradients are generated in liposomes containing ferrocyanide. , 1990, Bio Systems.
[18] M. Bally,et al. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. , 1990, Cancer research.
[19] M. Avron,et al. Determination of ΔpH in Chloroplasts , 1972 .
[20] M. Bally,et al. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. , 1990, Chemistry and physics of lipids.
[21] M. Bally,et al. Techniques for encapsulating bioactive agents into liposomes. , 1986, Chemistry and physics of lipids.
[22] M. Bally,et al. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. , 1989, Cancer research.
[23] Y. Barenholz,et al. Preparation and Characterization of Liposomal Doxorubicin for Human Use , 1992 .
[24] S M Gruner,et al. Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles. , 1985, Biochemistry.
[25] M. Bally,et al. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.
[26] A. Gabizon,et al. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. , 1989, Journal of the National Cancer Institute.
[27] C. J. Chapman,et al. Effects of solute concentration on the entrapment of solutes in phospholipid vesicles prepared by freeze-thaw extrusion. , 1991, Chemistry and physics of lipids.
[28] Y. Barenholz,et al. Stability of liposomal doxorubicin formulations: Problems and prospects , 1993, Medicinal research reviews.
[29] Y. Barenholz,et al. In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release. , 1992, Biochimica et biophysica acta.
[30] G. R. Bartlett. Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.
[31] Y. Barenholz,et al. The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior. , 1990, Biochimica et biophysica acta.
[32] Y. Barenholz,et al. Evaluation of a New Extrusion Device for the Production of Stable Oligolamellar Liposomes in a Liter Scale , 1989 .
[33] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[34] Y. Barenholz,et al. Optimization and upscaling of doxorubicin-containing liposomes for clinical use. , 1990, Journal of pharmaceutical sciences.
[35] T. Burke,et al. Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: an equilibrium binding study. , 1985, Biochemistry.
[36] G. Karlström,et al. Phase equilibria in the phosphatidylcholine-cholesterol system. , 1987, Biochimica et biophysica acta.
[37] Y. Barenholz,et al. Gelation of liposome interior A novel method for drug encapsulation , 1992, FEBS letters.
[38] N. Nissen,et al. Membrane transport of anthracyclines. , 1982, Pharmacology & therapeutics.